Cytosorbents Corp (CTSO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CTSO? Forum Prognose Aktiensplit

Finanzdaten der Cytosorbents Corp-Aktie (CTSO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.37% 9.485	9.617	8.7272	6.5232	9.3904
Cost Of Revenue	0.57% 2.819	2.803	2.5196	-0.2479	4.1088
Gross Profit	2.17% 6.666	6.814	6.2076	6.7711	5.2816
Operating Expenses	8.64% 9.528	10.43	10.09	10.82	9.6779
Benefits Costs and Expenses	13.06	-	10.21	16.10	11.72
Costs And Expenses	1.33% 13.06	13.23	10.21	16.10	11.72
Depreciation and Amortization	10.01% 0.364	0.4045	0.3685	0.3894	0.3828
Operating Income/Loss	20.83% -2.862	-3.615	-3.8872	-4.0454	-4.3962
Nonoperating Income/Loss	112.75% -0.709	5.562	2.4089	-5.5293	2.0622
Income/Loss From Continuing Operations Before Tax	137.13% -3.571	9.617	-1.4784	-9.5747	-2.3341
Income Tax Expense/Benefit	-0.401	-	-	-1.6908	-
Income/Loss From Continuing Operations After Tax	262.81% -3.17	1.947	-1.4784	-7.8839	-2.3341
Net Income/Loss	262.81% -3.17	1.947	-1.4784	-7.8839	-2.3341
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.23% 62.75	62.61	60.73	0.094	54.45
Diluted Average Shares	6.57% 62.75	67.17	60.73	0.094	54.45
Basic Earnings Per Share	266.67% -0.05	0.03	-0.02	-0.14	-0.05
Diluted Earnings Per Share	266.67% -0.05	0.03	-0.02	-0.14	-0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%